Related Experiment Videos
Toxicity of 8-methoxypsoralen in cynomolgous monkeys (Macaca fascicularis)
T Rozman1, F Leuschner, R Brickl
1Medizinische Forschung und Entwicklung der Basotherm GmbH, F.R.G.
Abstract:
Male and female cynomolgous monkeys were administered 0, 2, 6 or 18 mg/kg 8-methoxypsoralen (8-MOP) 3 times a week orally for 26 consecutive weeks. Dose-dependent emesis was the most sensitive indicator of 8-MOP toxicity. The lowest dose to elicit emesis was 3 x 6 mg/kg/week of 8-MOP. Among the histological findings proliferation of Kupffer cells was the only recurring observation. However, these finding as well as some hematological and serum electrolyte changes lacked a dose-response relationship. In the highest dosage group one female monkey was found in moribund condition on the 39th day of the study and was killed. Histopathological evidence indicated beginning shock as the cause of the rapidly deteriorating health of the monkey. Similar to effects in man and rats, 8-MOP displayed nonlinear pharmacokinetics in the cynomolgous monkey, saturation occurring between 3 x 2 and 3 x 6 mg/kg/week. Increased clearance of 8-MOP in the lowest dosage group after 26 test weeks was attributed to a combination of enzyme induction and saturable first pass effect. Since the plasma profile of 8-MOP at the lowest dose (3 x 2 mg/kg/week) in cynomolgous monkeys closely resembles that in humans after therapeutic doses (0.4-0.6 mg/kg) and because of other similarities (vomiting as earliest sign of toxicity, saturable first pass effect), it is reasonable to assume that chronic toxicity of 8-MOP as defined in this study is quite predictive for man.
Insights
This study found that vomiting is the earliest sign of 8-methoxypsoralen (8-MOP) toxicity in cynomolgous monkeys. The drug
Area of Science:
- Pharmacology
- Toxicology
- Primate Studies
Background:
- 8-methoxypsoralen (8-MOP) is a compound with therapeutic applications.
- Understanding its chronic toxicity profile is crucial for human safety.
- Non-human primate models are often used to predict human responses.
Purpose of the Study:
- To evaluate the chronic oral toxicity of 8-methoxypsoralen (8-MOP) in cynomolgous monkeys.
- To identify the most sensitive indicators of 8-MOP toxicity.
- To assess the pharmacokinetic profile and predict human relevance.
Main Methods:
- Male and female cynomolgous monkeys received oral 8-MOP (0, 2, 6, or 18 mg/kg) thrice weekly for 26 weeks.
- Dose-response relationships for toxicity and pharmacokinetic parameters were analyzed.
- Histopathological examination and clinical observations were conducted.
Main Results:
- Dose-dependent emesis was the most sensitive indicator of 8-MOP toxicity, occurring at 3 x 6 mg/kg/week.
- Kupffer cell proliferation was observed histologically but lacked dose-response.
- Nonlinear pharmacokinetics with saturation between 3 x 2 and 3 x 6 mg/kg/week were noted.
Conclusions:
- Vomiting is the earliest sign of 8-MOP toxicity in cynomolgous monkeys.
- The pharmacokinetic profile and toxicity of 8-MOP in monkeys resemble those in humans.
- This study suggests that chronic toxicity findings in cynomolgous monkeys are predictive for humans.